Clinical Trial Update: Decitabine Plus R-CHOP in Diffuse Large B-cell Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for decitabine plus R-CHOP in diffuse large B-cell lymphoma (Phase 1/Phase 2) with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Decitabine (Decitabine)
• R-CHOP

Snippet

Sponsor: Ruijin Hospital | Conditions: Diffuse Large B Cell Lymphoma | Phase 1, Phase 2 | Status: UNKNOWN